Company profile: Caidya
1.1 - Company Overview
Company description
- Provider of clinical research services with personalized solutions across therapeutic areas, supported by a proprietary technology platform that integrates data from different systems to create a near real-time view of clinical trials.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Caidya
Phlow
HQ: United States
Website
- Description: Provider of affordable, quality essential medicines using U.S.-based advanced manufacturing processes. Helps ensure the quality, safety, and affordability of pharmaceutical products of strategic importance to the United States, leveraging advanced manufacturing platforms, including continuous manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phlow company profile →
Sterigenics
HQ: United States
Website
- Description: Provider of contract sterilization and ionization supply chain management solutions for medical device and pharmaceutical industries, using Ethylene Oxide (EO), Gamma and Electron Beam (E-Beam) irradiation. Also offers process capabilities for food safety and high performance specialty materials, VeriCycle automated EO process verification, and Sterigenics GPS end-to-end, real-time global processing status visibility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sterigenics company profile →
ScanModul
HQ: Germany
Website
- Description: Provider of engineered healthcare storage equipment and services throughout Europe, offering ISO-certified modular tray and basket systems, mobile ScanCell storage solutions, SmartCabinet RFID systems for real-time management of medical devices and implants, and NoCount software supporting hospital supply-chain planning and delivery based on actual needs, enabling automatic data capture to increase efficiency and safety.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ScanModul company profile →
Invivyd
HQ: United States
Website
- Description: Provider of antibody-based therapies to protect vulnerable people from serious viral infectious diseases. Offers PEMGARDA, authorized for emergency use as pre-exposure prophylaxis against COVID-19 in certain adults and adolescents; the INVYMAB platform combining viral surveillance, predictive modeling, and antibody engineering; a pipeline of COVID-19 and influenza monoclonal antibody candidates; and clinical trials, including the CANOPY Phase 3 trial.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Invivyd company profile →
CancerVax
HQ: United States
Website
- Description: Provider of novel biological products for cancer treatment and control, focused on specific active immunotherapy. Offerings include a Universal Cancer Vaccine (UCV) platform that forces cancer cells to express a unique protein marker for precise immune targeting, a Universal CAR-T (UCAR-T) platform that reprograms natural T-cells inside the body to destroy targeted cancer cells, and an Ewing sarcoma immunotherapy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CancerVax company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Caidya
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Caidya
2.2 - Growth funds investing in similar companies to Caidya
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Caidya
4.2 - Public trading comparable groups for Caidya
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →